Found: 18
Select item for more details and to access through your institution.
NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals.
- Published in:
- Molecular Medicine, 2022, v. 28, n. 1, p. 1, doi. 10.1186/s10020-022-00443-2
- By:
- Publication type:
- Article
Risk‐adapted bendamustine + rituximab is a tolerable treatment alternative for elderly patients with chronic lymphocytic leukaemia: a regional real‐world report on 141 consecutive Swedish patients.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 3, p. 426, doi. 10.1111/bjh.17032
- By:
- Publication type:
- Article
Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0142310
- By:
- Publication type:
- Article
Ibrutinib versus previous standard of care: an adjusted comparison in patients with relapsed/refractory chronic lymphocytic leukaemia.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase I-II study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukemia (CLL): effects on T cells and immune checkpoints.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 91, doi. 10.1007/s00262-016-1922-6
- By:
- Publication type:
- Article
T cells from indolent CLL patients prevent apoptosis of leukemic B cells in vitro and have altered gene expression profile.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 1, p. 51, doi. 10.1007/s00262-012-1300-y
- By:
- Publication type:
- Article
Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 6, p. 865, doi. 10.1007/s00262-011-1149-5
- By:
- Publication type:
- Article
Incidence of cardiovascular and bleeding events and reasons for discontinuation in patients with chronic lymphocytic leukemia treated with ibrutinib--A retrospective analysis on consecutive patients from a well-defined region.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 5, p. 748, doi. 10.1111/ejh.14072
- By:
- Publication type:
- Article
Idelalisib (PI3Kδ inhibitor) therapy for patients with relapsed/refractory chronic lymphocytic leukemia: A Swedish nation-wide real-world report on consecutively identified patients.
- Published in:
- European Journal of Haematology, 2023, v. 111, n. 5, p. 715, doi. 10.1111/ejh.14065
- By:
- Publication type:
- Article
Long-term effects of idiotype vaccination on the specific T-cell response in peripheral blood and bone marrow of multiple myeloma patients.
- Published in:
- European Journal of Haematology, 2007, v. 79, n. 5, p. 371, doi. 10.1111/j.1600-0609.2007.00962.x
- By:
- Publication type:
- Article
SARS-CoV-2 vaccination enhances the effector qualities of spike-specific T cells induced by COVID-19.
- Published in:
- Science Immunology, 2023, v. 8, n. 90, p. 1, doi. 10.1126/sciimmunol.adh0687
- By:
- Publication type:
- Article
Phase I study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukaemia: maintaining immune functions during therapy-induced immunosuppression.
- Published in:
- British Journal of Haematology, 2012, v. 159, n. 5, p. 0, doi. 10.1111/bjh.12077
- By:
- Publication type:
- Article
research paper Signalling molecules and cytokine production in T cells of multiple myeloma-increased abnormalities with advancing stage.
- Published in:
- British Journal of Haematology, 2004, v. 124, n. 3, p. 315, doi. 10.1046/j.1365-2141.2003.04789.x
- By:
- Publication type:
- Article
Additive effects of booster mRNA vaccination and SARS-CoV-2 Omicron infection on T cell immunity across immunocompromised states.
- Published in:
- Science Translational Medicine, 2023, v. 15, n. 704, p. 1, doi. 10.1126/scitranslmed.adg9452
- By:
- Publication type:
- Article
A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib.
- Published in:
- PLoS ONE, 2018, v. 13, n. 5, p. 1, doi. 10.1371/journal.pone.0198038
- By:
- Publication type:
- Article
Real‐world data on treatment concepts in classical Hodgkin lymphoma in Sweden 2000–2014, focusing on patients aged >60 years.
- Published in:
- EJHaem, 2021, v. 2, n. 3, p. 400, doi. 10.1002/jha2.202
- By:
- Publication type:
- Article
Temporary cessation of ibrutinib results in reduced grade 3‐4 infections and durable remissions—Interim analysis of an on‐off‐repeat Phase 1b/2 study in patients with chronic lymphocytic leukemia.
- Published in:
- EJHaem, 2021, v. 2, n. 3, p. 525, doi. 10.1002/jha2.261
- By:
- Publication type:
- Article
Autologous T cells expressing the oncogenic transcription factor KLF6-SV1 prevent apoptosis of chronic lymphocytic leukemia cells.
- Published in:
- PLoS ONE, 2018, v. 13, n. 2, p. 1, doi. 10.1371/journal.pone.0192839
- By:
- Publication type:
- Article